taphylococcus aureus is an invasive pathogen that causes skin and soft tissue infections (SSTI), bacteremia, sepsis and endocarditis (1) . In the United States, an annual mortality of more than 20,000 is attributed to S. aureus infection, exceeding deaths caused by influenza, viral hepatitis, and HIV/AIDS (2) . Of particular concern are patients with recurrent invasive infections, which occur in up to 13% of individuals with surgical and antibiotic therapy (3) . Recurrent infection leads to invasive S. aureus disease with bacteremia but is not associated with the development of immunity (4) . Antibiotic-resistant strains, designated MRSA (methicillin-resistant S. aureus), cause community-as well as hospital-acquired infections and represent a major public health problem (5) . Although there is a clear need for a vaccine against S. aureus (6), past clinical trials with whole-cell vaccines and with purified subunits have failed (7, 8) .
Intravenous S. aureus infection of mice leads to disseminated, persistent abscess formation and to lethal disease (9) . Similar to humans, infected animals raise antibodies against some of the secreted products of S. aureus but generally fail to develop protective immunity (10, 11) . The contributions of several virulence mechanisms for staphylococcal infection have been revealed, including blood coagulation (12) , agglutination with fibrin cables (13, 14) , adenosine synthesis (15) , heme iron scavenging (16) , toxin-mediated dissemination (17) , and escape from complement activation (18, 19) . These mechanisms are important for the establishment of disease; however, they are not known to be required for staphylococcal escape from host adaptive immune responses (20) . Recent work implemented protein A (SpA) as a vaccine antigen (11) , and this prompted us to investigate its contribution to staphylococcal escape from protective immune responses. SpA is anchored in the bacterial cell wall envelope and released during staphylococcal growth (21) . Each of its five immunoglobulin-binding domains (IgBDs) captures the Fc␥ domain of human or mouse IgG (22) as well as the Fab domain of V H 3 clan IgG and IgM (23) . Fc␥ binding to SpA is thought to protect staphylococci from opsonophagocytic killing (24) . Moreover, purified SpA triggers B cell superantigen activity through cross-linking of V H 3 type B cell receptors (surface IgM), resulting in proliferative supraclonal expansion as well as apoptotic collapse of the activated B cells (25) .
When used as a subunit vaccine, SpA variants that are unable to capture IgG Fc␥ and cross-link B cell receptors elicit protein A-neutralizing antibodies in mice, which protect these animals against S. aureus abscess formation (11) . SpA-neutralizing antibodies also enable infected animals to mount antibody responses against many different staphylococcal antigens (11) . Similar protective effects are achieved when protein A-neutralizing monoclonal antibodies are passively transferred into naive mice (26) . Here we asked whether protein A represents the key immune-evasive determinant of S. aureus by infecting mice with spa variants lacking the ability to capture IgG Fc␥ and/or to cross-link B cell receptors.
RESULTS

S. aureus spa variants defective for immunoglobulin binding.
Guided by the structural analysis of protein A cocrystallized with Fc␥ or Fab (27, 28) , we generated SpA variants with amino acid substitutions at residues 9 and 10 (Gln 9 -Lys and Gln 10 -Lys) and/or residues 36 and 37 (Asp 36 -Ala and Asp 37 -Ala) of all five IgBDs, which retained the alpha-helical fold of the immunoglobulin-binding domains ( Fig. 1A and 2B ). When substitutions were introduced into recombinant protein A and the resulting mutant proteins were analyzed for the binding of purified polypeptides to human immunoglobulin, it was found that specific substitutions abolished the association of recombinant SpA with Fc␥ (SpA KK ), Fab (SpA AA ), or Fc␥ and Fab (SpA KKAA ) (26) (Fig. 2A) . The corresponding mutations were introduced into the coding sequence for each of the five IgBDs of the spa gene (Fig. 1A) . S. aureus wild-type strain Newman (29, 30) and its isogenic variants carrying a deletion of spa (⌬spa), the Gln 9 -Lys and Gln 10 -Lys substitutions (spa KK ), the Asp 36 -Ala and Asp 37 -Ala substitutions (spa AA ), or both sets of substitutions within the same protein A gene (spa KKAA ) were probed by immunoblotting with specific antibodies (Fig. 1B) . Similar amounts wild-type and mutant SpA were detected in the bacterial envelope and in the extracellular medium of S. aureus cultures, indicating that the substitutions did not affect expression, surface display, or stability of mutant protein A molecules (Fig. 1BC) . The secretion of Sbi, a second staphylococcal IgG binding protein with homology to SpA (31), was also not impacted by spa mutations (Fig. 1B) . Binding of protein A on the surface of wild-type S. aureus to fluorophoreconjugated Fc␥ or F(ab) 2 domains of human immunoglobulin was revealed via flow cytometry (Fig. 1C) . In contrast to wild-type staphylococci, the binding to Fc␥ was abolished in the spa KK and spa KKAA variants but not in the spa AA mutant (Fig. 1C) . The binding of human F(ab) 2 fragments to spa AA and spa KKAA mutants was reduced, but it was not affected in the spa KK variant (Fig. 1C) . The residual amount of F(ab) 2 fragment binding to the spa KKAA mutant is likely based on antibody recognition of staphylococcal surface antigens, as similar binding activities were observed for S. aureus mutants lacking the entire spa gene (⌬spa) (Fig. 1C) .
Contribution of protein A to staphylococcal virulence. The virulence of wild-type and spa mutant staphylococci was assessed by intravenous injection of 1 ϫ 10 7 CFU into naive BALB/c mice. Animals were euthanized 15 days after challenge and necropsied, and staphylococcal load and abscess formation in renal tissues were determined ( Table 1 ). The spa KKAA variant was attenuated for both abscess formation in renal tissues and staphylococcal load, similar to the ⌬spa mutant (32) ( Table 1 Immunoevasive attributes of protein A during S. aureus infection of mice. To further explore the contributions of protein A to S. aureus disease, we infected mice by intravenous inoculation into the retroorbital plexus, removed blood samples after 30 min by cardiac puncture, and enumerated staphylococcal CFU. Wildtype and spa AA mutant S. aureus survived in the bloodstream of naive mice, whereas reduced numbers of the ⌬spa, spa KK , and spa KKAA variants were isolated from blood (Fig. 3A) . The reduced bacterial load in blood is likely due to increased killing by phagocytes, as an in vitro opsonophagocytosis assay with anticoagulated mouse blood revealed increased killing of the ⌬spa, spa KK , and spa KKAA variants (Fig. 3B ). Compared to that in wildtype C57BL/6 mice, the survival of wild-type S. aureus was re- duced in the bloodstream of MT mice, which lack both mature B cells and immunoglobulin (Fig. 3A) . Further, no significant difference in bloodstream survival in MT mice was detected between wild-type and spa KKAA mutant S. aureus (Fig. 3A) . Interestingly, addition of affinity-purified immunoglobulin G and M to anti-coagulated MT mouse blood restored protein A-mediated resistance against opsonophagocytosis (Fig. 3C ). (Fig. 5A) . When subjected to flow cytometry with mouse IgM and IgG, antibodies of both Ig types bound to the surface of the spa KKAA sbi mutant (Fig. 5B) . These natural antibodies against S. aureus were detected in sera from naive BALB/c and C57BL/6 animals but not in MT mice. To discern whether natural antibodies provide protection against S. aureus, C57BL/6 and MT mice were infected with wild-type and spa KKAA or spa KKAA sbi S. aureus strains. As expected, the staphylococcal load and abscess formation in organ tissues from spa KKAA infected animals were lower than those of mice infected with wildtype S. aureus (Table 2 ). Mice infected with the spa KKAA sbi mutant did not display a further reduction in bacterial load and abscess formation ( Table 2 ). The virulence defects associated with wildtype spa were not observed in MT mice, as similarly low numbers of bacteria and abscesses were isolated from organ tissues of MT Survival of wild-type and spa mutant S. aureus Newman injected into the bloodstream of wild-type C57BL/6 or MT mice, lacking mature B cells and immunoglobulin (n ϭ 5; data are means Ϯ standard errors of the means [SEM]; *, P Ͻ 0.05). (B) Anti-coagulated mouse blood (n ϭ 3) was incubated with 5 ϫ 10 5 CFU of S. aureus Newman (wild-type) and its ⌬spa, spa KK , spa AA , and spa KKAA variants for 30 min. Staphylococcal escape from phagocytic killing was measured by enumerating CFU in lysed blood samples. Average survival of staphylococci was calculated from three independent experimental determinations and analyzed by assigning the survival of wild-type S. aureus as 100%. Survival of each mutant was analyzed in pairwise comparison with wild-type S. aureus (*, P Ͻ 0.05). (C) Anti-coagulated mouse blood (n ϭ 3) from C57BL/6 or MT mice with or without exogenous addition of purified mouse IgG and IgM (2 mg ml Ϫ1 and 0.4 mg ml Ϫ1 , respectively) was incubated with 5 ϫ 10 5 CFU of wild-type or spa KKAA mutant S. aureus for 30 min, and bacterial survival was measured (*, P Ͻ 0.05).
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animals infected with wild-type, spa KKAA , or spa KKAA sbi strains (Table 2) . Further, similarly low staphylococcal loads and abscess numbers were detected in C57BL/6 and MT mice infected with either the spa KKAA or spa KKAA sbi mutant (Table 2 ). These data therefore suggest that natural IgG and IgM antibodies of mice do not provide protection against staphylococci and that Sbi binding to IgG does not contribute to S. aureus virulence.
DISCUSSION
Following the discovery of S. aureus binding to immunoglobulin, Sjöquist and colleagues purified protein A and revealed its binding to the Fc␥ domain of human and animal immunoglobulins (35, 36) . This biochemical activity allows exogenously supplied protein A to block complement-dependent (opsono)phagocytosis of S. aureus or Escherichia coli by human neutrophils (37) . Purified protein A was also shown to exert mitogen activity for human B cells (24) . Nevertheless, mice with heritable B cell deficiencies, for example, a mutation in Bruton's tyrosine kinase (X-linked immunodeficiency) (38) or gene-targeted B-cell ablation (MT) (39), display similar or reduced disease progression in S. aureus sepsis or septic arthritis models as wild-type animals (40, 41) . These findings were interpreted as evidence that, unlike neutrophils or Th17 T cells (42) (43) (44) (45) , neither antibodies nor B cells contribute to the pathogenesis of S. aureus infections or affect host susceptibility to staphylococcal infection (40) .
More recently, it was discovered that protein A binds also to the Fab domain of immunoglobulin heavy chains (IgG, IgA, IgM, and IgE) (46) , specifically to the Fab domains of human and mouse V H 3 clan antibodies (47) (48) (49) . Protein A binding to IgM triggers cross-linking of B cell receptors, proliferative supraclonal expansion, and apoptotic collapse of activated B cells (25) . This B cell superantigen activity can be demonstrated in mice injected with purified protein A as prolonged ablation-adaptive B cell responses (50) . Following intravenous inoculation of mice with staphylococci, wild-type S. aureus replicates in abscess lesions in many different tissues, including the kidneys (51), and also causes septic arthritis (52) . Compared to wild-type staphylococci, S. aureus ⌬spa mutants display defects in renal abscess formation, septic arthritis, and lethal sepsis (9, 32, 52 KK and spa AA variants displayed incremental defects in the pathogenesis of systemic infections. Furthermore, the virulence contributions of S. aureus protein A are not observed in MT mice, which lack both mature B cells and their antibody products (39) . Unlike infection with wild-type staphylococci, infection with S. aureus spa KKAA elicits immune responses that partially protect mice from a lethal challenge with the highly virulent strain LAC (USA300), which is responsible for the current epidemic of communityassociated MRSA infections (33) . Similar to S. aureus, Mycobacterium tuberculosis infection of humans or animals causes distinctive lesions, i.e., granulomas, and is also not associated with the development of protective immunity against disease (tuberculosis) (53) . Bacillus CalmetteGuérin (BCG) infection, which is not associated with granuloma formation among other defects, raises protective T cell immune responses against tuberculosis (54, 55) . At least in mice, BCGderived immunity is impaired in mice with a defect in Bruton's tyrosine kinase and X-linked immune deficiency (XID), a disease with impaired B lymphocyte function (56) . XID mice lack the activity of B cells to down-regulate neutrophil motility in order to promote macrophage-mediated phagocytosis, antigen presentation as well as clearance of mycobacteria (56) . In view of these findings, we cannot exclude the possibility that defects in S. aureus pathogenesis in MT mice not only may be due to the absence of immunoglobulin (as shown in Fig. 3BC ) but also may be affected by B cell-dependent neutrophil motility at sites of staphylococcal infection.
In summary, the data reported here explain the seeming paradox that protein A, an Ig-binding protein and B cell superantigen, functions as a key virulence factor for the pathogenesis of S. aureus infections, whereas heritable B cell and/or antibody deficiencies are not associated with defects in the development of immunity to staphylococcal infection. We propose that S. aureus expression of protein A and its binding to Ig ameliorate B cell responses during infection, thereby interfering with the development of protective immunity. This model may explain why heritable defects in humoral immune responses cannot affect host susceptibility to staphylococcal infection-protein A effectively disables humoral immune responses. In contrast, perturbation of staphylococcal virulence via mutations in protein A, immunization with nontoxigenic protein A or administration of protein A-neutralizing monoclonal antibodies each can elicit protective antibodies in mice against highly virulent MRSA strains (11, 26) . We therefore propose that SpA KKAA represents a protective antigen for the development of a staphylococcal vaccine.
MATERIALS AND METHODS
Bacterial strains. S. aureus strains Newman and its variants or USA300 LAC were grown in tryptic soy broth (TSB) or agar at 37°C. E. coli strains DH5␣ and BL21(DE3) were grown in Luria broth (LB) or agar at 37°C. Ampicillin (100 g ml Ϫ1 for E. coli), spectinomycin (200 g ml Ϫ1 for S. aureus), and erythromycin (20 g ml Ϫ1 for S. aureus) were used for plasmid selection (pET15bϩ), mutant allele selection (⌬spa), and transposon selection (⌬sbi).
S. aureus spa mutants. Two 1-kb DNA sequence segments upstream and downstream of the spa gene were amplified from the chromosome of S. aureus Newman (30) with primers ext1F (5= GGGGACCACTTTGTA CAAGAAAGCTGGGTCATTTAAGAAGATTGTTTCAGATTTATG 3=), ext1R (5= ATTTGTAAAGTCATCATAATATAACGAATTATGTATTGC AATACTAAAATC 3=), ext2F (5= CGTCGCGAACTATAATAAAAACAA ACAATACACAACGATAGATATC 3=), and ext2R (5= GGGGACAAGTT TGTACAAAAAAGCAGGCAACGAACGCCTAAAGAAATTGTCTTTG C 3=). The DNA sequences of spa KKAA , spa AA , and spa KK mutants were previously described (26) . These sequences were amplified using the primers spaF (CATAATTCGTTATATTATGATGACTTTACAAATACA TACAGGG) and spaR (GTATTGTTTGTTTTTATTATAGTTCGCGAC GACGTCCA). For each construct, mutant spa genes and their two flanking regions were fused together in a subsequent PCR. The final PCR products were cloned into pKOR1 using the BP Clonase II kit (Invitrogen). Plasmids were electroporated into the S. aureus ⌬spa variant and temperature shifted to 42°C, blocking replication of plasmids and promoting their insertion into the chromosome. Growth at 30°C was used to promote allelic replacement. Mutations in the spa genes were verified by DNA sequencing of PCR amplification products.
Purification of protein A. E. coli BL21(DE3) harboring pET15bϩ plasmids for the expression of His-tagged wild-type SpA, SpA KK , SpA AA , and SpA KKAA (26) was grown overnight, diluted 1:100 into fresh medium, and grown at 37°C to an A 600 of 0.5. Cultures were induced with 1 mM isopropyl ␤-D-1-thiogalatopyranoside (IPTG) and grown for an additional 3 h. Bacterial cells were sedimented by centrifugation, suspended in column buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl) and disrupted with a French pressure cell at 14,000 lb/in 2 . Lysates were cleared of membrane and insoluble components by ultracentrifugation at 40,000 ϫ g. Cleared lysates were subjected to nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography, and proteins were eluted in column buffer containing successively higher concentrations of imidazole (100 to 500 mM). Eluates were dialyzed with phosphate-buffered saline (PBS), treated with Triton-X114 to remove endotoxin, and again dialyzed with PBS. Protein concentrations were determined by bicinchoninic acid (BCA) assay (Thermo Scientific). Purity was verified by Coomassie-stained SDS-PAGE.
Circular dichroism (CD) spectroscopy. Far ultraviolet (UV) CD, spectra of purified SpA, SpA AA , SpA KK , and SpA KKAA in 10 mM phosphate buffer (pH 7.2), 50 mM Na 2 SO 4 were recorded on an AVIV 202 CD spectrometer (University of Chicago Biophysics Core Facility) at room temperature.
Immunofluorescence microscopy. Overnight cultures of staphylococci were diluted 1:100 and grown at 37°C with shaking to A 600 0.7. Bacteria were centrifuged, washed, fixed with glutaraldehyde and blocked. Cells were incubated with affinity purified anti-SpA KKAA rabbit IgG for 1 h, washed, incubated with Alexafluor 647-conjugated goat anti-rabbit IgG (Invitrogen), and washed in PBS. Bacteria were settled in polylysinetreated glass coverslips and then applied to glass coverslips containing a drop of SlowFade anti-fading reagent (Invitrogen). Images were captured on a Leica SP5 tandem-scanner spectral two-photon confocal microscope at the University of Chicago Light Microscopy Core Facility.
Flow cytometry. Overnight cultures of staphylococci grown in TSB were diluted 1:100 and grown at 37°C with shaking to an A 600 of 0.6. Bacteria were centrifuged, washed, fixed, and blocked. To analyze immunoglobulin binding to staphylococci, cells were incubated with fluorescein isothiocyanate (FITC)-conjugated Fc␥ or F(ab) 2 fragments of human IgG (1:250) and washed in 1% BSA-PBS. To examine the presence of natural antibodies against S. aureus in naive mouse serum, staphylococci were incubated with dilutions of naive mouse sera (C57BL/6 and BALB/c; Taconic) for 30 min at room temperature with slow rotation. Cells were washed, incubated with phycoerythrin-conjugated goat anti-mouse IgM or FITC-conjugated goat anti-mouse IgG (1:250), and washed in 1% BSA-PBS.
Affinity chromatography of immunoglobulin. Purified His 6 -tagged SpA, SpA AA , SpA KK , and SpA KKAA were immobilized on nickelnitrilotriacetic acid (Ni-NTA) Sepharose, washed, and incubated with human IgG or Fc or F(ab) 2 fragments in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl buffer. After being washed, proteins were eluted with 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 500 mM imidazole and analyzed by SDS-PAGE.
Staphylococcal survival in blood in vitro. Whole blood was collected from mice by cardiac puncture, and coagulation was inhibited with 10 g ml Ϫ1 lepirudin. S. aureus Newman or its variants (50 l, 5 ϫ 10 5 CFU ml Ϫ1 ) were mixed with 400 to 950 l of mouse blood in the presence or absence of affinity-purified mouse IgG and IgM (2 mg ml Ϫ1 and 0.4 mg ml Ϫ1 , respectively). Samples were incubated at 37°C with slow rotation for 30 min and then incubated on ice with 1% saponin-PBS to lyse eukaryotic cells. Dilutions of staphylococci were plated on agar for colony formation.
Enzyme-linked immunosorbent assay. To determine antigenspecific serum IgG, recombinant purified staphylococcal antigens (SpA K -KAA, ClfA, FnBPB, IsdB, Coa, and Hla) (11) were used to coat enzymelinked immunosorbent assay (ELISA) plates at 1 g ml Ϫ1 in 0.1 M carbonate buffer (pH 9.5 at 4°C overnight). The following day, plates were blocked and incubated with serially diluted sera. Plates were incubated with horseradish peroxidase-conjugated secondary antibody specific to mouse IgG (or isotype specific antibodies) and developed using OptEIA reagent.
Protein A expression in S. aureus. Overnight cultures of staphylococci were diluted 1:100 and grown at 37°C with shaking to an A 600 of 2. For fractionation of staphylococci, cultures were centrifuged, and the extracellular medium in supernatant was precipitated with 5% trichloroacetic acid (TCA). The pellet was suspended in TSM [50 mM Tris (pH 7.5), 500 mM sucrose, and 10 mM MgCl 2 with 100 g ml Ϫ1 lysostaphin] and incubated at 37°C to solubilize the cell wall envelope. The resulting protoplasts were sedimented by centrifugation, and the supernatant was precipitated with TCA (cell wall fraction). TCA-precipitated proteins were washed in acetone, dried, solubilized in sample buffer, and separated by SDS-PAGE. Proteins were electrotransferred to polyvinylidene difluoride (PDVF) membranes and analyzed by immunoblotting using affinity-purified rabbit anti-SpA KKAA antibody (11) .
Active immunization. Three-week-old female BALB/c mice (Charles River Laboratories) were immunized with 50 g of SpA or its variants emulsified in complete Freund's adjuvant (CFA; Difco) and given boosters of 50 g of the same antigen emulsified in incomplete Freund's adjuvant (IFA) 11 days following the first immunization. On day 21, mice were bled, and serum was recovered for ELISAs.
Mouse renal abscess model. Overnight cultures of S. aureus Newman (wild-type) and its ⌬spa, spa AA , spa KK , and spa KKAA variants were diluted 1:100 into fresh TSB and grown for 2 h at 37°C. Staphylococci were sedimented, washed, and suspended in PBS to the desired bacterial concentration. Inocula were quantified by spreading sample aliquots on TSA and enumerating CFU. BALB/c mice were anesthetized via intraperitoneal injection with 65 mg ml Ϫ1 ketamine and 6 mg ml Ϫ1 xylazine per kilogram of body weight. Mice were infected by injection with 1 ϫ 10 7 CFU of S. aureus Newman or its variants into the periorbital venous sinus of the right eye. On day 15 or 28 following infection, mice were euthanized by CO 2 inhalation and cervical dislocation. Both kidneys were removed, and the staphylococcal load in one organ was analyzed by homogenizing renal tissue with PBS, 0.1% Triton X-100. Serial dilutions of homogenate were spread on TSA and incubated for colony formation. The remaining organ was examined by histopathology. Briefly, kidneys were fixed in 10% formalin for 24 h at room temperature. Tissues were embedded in paraffin, thin-sectioned, stained with hematoxylin-eosin, and inspected by light microscopy to enumerate abscess lesions. Immune serum samples collected at 15 days postinfection were examined by ELISA against the staphylococcal antigen matrix. To examine whether attenuated strains elicit protective efficacy, animals were infected with the spa K -KAA mutant for 15 days and treated with daptomycin at 10 mg kg of body weight Ϫ1 for 4 days. Three days after the last injection of daptomycin, animals were challenged with 5 ϫ 10 7 CFU of S. aureus USA300 and monitored for 10 days. All mouse experiments were performed at least twice and conducted in accordance with the institutional guidelines following experimental protocol review and approval by the Institutional Biosafety Committee (IBC) and the Institutional Animal Care and Use Committee (IACUC) at the University of Chicago.
Staphylococcal survival in blood in vivo. Overnight cultures of S. aureus Newman and its ⌬spa, spa AA , spa KK , or spa KKAA variants were diluted 1:100 in fresh medium and grown for 2 h at 37°C. Staphylococci were sedimented by centrifugation, washed, and suspended in PBS to the desired bacterial concentration. Inocula were quantified by spreading sample aliquots on TSA and enumerating the colonies that formed upon incubation. C57BL/6J and B6.129S2-Ighm tm1Cgn /J (MT) mice (Jackson Laboratory) were anesthetized via intraperitoneal injection with 65 mg ml Ϫ1 ketamine and 6 mg ml Ϫ1 xylazine per kilogram of body weight. Mice were infected by injection with 1 ϫ 10 6 CFU of S. aureus into the periorbital venous sinus of the right eye. At 30 min postinfection, mice were euthanized by CO 2 inhalation. Blood was collected by cardiac puncture and mixed with 2% saponin-PBS in 1:1. Dilutions of staphylococci were plated on agar for colony formation.
Statistical analysis. Bacterial loads in the experimental animal infection model were analyzed with the two-tailed Mann-Whitney test to measure statistical significance. Unpaired two-tailed Student's t tests were performed to analyze the statistical significance of ELISA data, blood survival data, and abscess formation in the experimental animal infection model. All data were analyzed by Prism (GraphPad Software, Inc.), and P values less than 0.05 were deemed significant.
